Navigation Links
TriCipher Joins SAFE BioPharma Association Vendor Partner Program
Date:10/22/2007

les companies to deploy and manage multiple types of credentials from a single infrastructure. Through this flexible "Authentication Ladder," TriCipher protects customer investment by adjusting authentication strength to defeat new threats and to meet regulatory changes without the need to implement a new infrastructure. Founded in 2000, TriCipher is headquartered in Los Gatos, Calif. The company is funded by ArrowPath Venture Capital, Intel Capital, RBC Technology Ventures, Trident Capital, and Wasatch Venture Fund. For more information, visit TriCipher on the web at http://www.tricipher.com

About SAFE-BioPharma Association

SAFE-BioPharma Association is the non-profit association that created and manages the SAFE(TM) digital identity and digital signature standard for the pharmaceutical and healthcare industries. Through the SAFE standard, the association promotes interoperability and integration among researchers, vendors, regulators, clinicians and other pharmaceutical and healthcare stakeholders. The SAFE standard provides a secure, enforceable, and regulatory compliant way to verify the identities of parties involved in business-to- business and business-to-regulator electronic transactions. SAFE stands for "Signatures and Authentication For Everyone." The Association's members include Amgen, AstraZeneca, Bristol-Myers Squibb, Genzyme, GlaxoSmithKline, Johnson & Johnson, Merck, Pfizer, Procter & Gamble, Roche and Sanofi-Aventis. For more information visit http://www.safe-biopharma.org.

SAFE(TM) is a trademark of SAFE-BioPharma Association. Any use of this trademark requires approval from SAFE-BioPharma Association.


'/>"/>
SOURCE TriCipher, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Chemical-petroleum executive joins Virent Energy board
2. Schneider National exec joins TrafficCast board
3. Doyle joins governors in support of stem cell bill
4. Genomics researcher Hood joins NimbleGen board
5. Fergus joins Baird Venture Partners, Caden Bio
6. Meier joins Broadlook Technologies as COO
7. Prodesse joins forces with Invitrogen
8. Wisconsin joins price-fixing suit vs. D-RAM makers
9. Napier joins board of Third Wave Technologies
10. Schmidt rejoins Renaissance Learning
11. Tommy Thompson joins drug company as advisor
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):UAB bone center director wins distinguished service award from clinical pathology society 2H1N1 influenza adopted novel strategy to move from birds to humans 2H1N1 influenza adopted novel strategy to move from birds to humans 3H1N1 influenza adopted novel strategy to move from birds to humans 4Superior offspring without genetic modification 2Statement by John Bailey Chief Scientist The Personal Care Products Council Response to EWGs 2009 Sunscreen Report 50635 1Statement by John Bailey Chief Scientist The Personal Care Products Council Response to EWGs 2009 Sunscreen Report 50635 2Statement by John Bailey Chief Scientist The Personal Care Products Council Response to EWGs 2009 Sunscreen Report 50635 3Statement by John Bailey Chief Scientist The Personal Care Products Council Response to EWGs 2009 Sunscreen Report 50635 4Statement by John Bailey Chief Scientist The Personal Care Products Council Response to EWGs 2009 Sunscreen Report 50635 5Successful Beginning for Wellstone Muscular Dystrophy Center at Boston Biomedical Research Institute 50632 1Successful Beginning for Wellstone Muscular Dystrophy Center at Boston Biomedical Research Institute 50632 2Study Casts Doubt on Low IQs Role in Early Death 50630 1Study Casts Doubt on Low IQs Role in Early Death 50630 2